Advisor Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$7.63M Sell
117,270
-12,880
-10% -$839K 0.05% 290
2019
Q3
$8.26M Buy
130,150
+14,340
+12% +$937K 0.06% 270
2019
Q2
$7.83M Buy
115,810
+6,130
+6% +$403K 0.06% 277
2019
Q1
$7.14M Sell
109,680
-7,031
-6% -$467K 0.06% 290
2018
Q4
$7.31M Sell
116,711
-33,858
-22% -$2.37M 0.07% 225
2018
Q3
$11.6M Buy
150,569
+24,496
+19% +$1.85M 0.12% 153
2018
Q2
$8.93M Sell
126,073
-14,681
-10% -$1.04M 0.12% 158
2018
Q1
$10.6M Sell
140,754
-25,297
-15% -$2.01M 0.15% 136
2017
Q4
$11.9M Buy
166,051
+20,924
+14% +$1.59M 0.16% 121
2017
Q3
$11.8M Buy
145,127
+2,362
+2% +$181K 0.19% 108
2017
Q2
$10.1M Sell
142,765
-7,124
-5% -$474K 0.18% 116
2017
Q1
$10.2M Sell
149,889
-41,052
-21% -$2.89M 0.21% 103
2016
Q4
$13.7M Buy
190,941
+10,683
+6% +$794K 0.31% 61
2016
Q3
$14.3M Buy
180,258
+10,827
+6% +$880K 0.34% 51
2016
Q2
$14.1M Buy
+169,431
New +$15M 0.37% 49

Other funds holding GILD

Advisor Group's GILD Position: Q4 2019 in Review

Advisor Group reduced its Gilead Sciences (GILD) stake by 9.9% in Q4 2019, selling an estimated $839K and leaving 117,270 shares worth $7.63M. The position accounts for 0.05% of the portfolio, ranked #290.

Advisor Group first reported a position in GILD in Q2 2016 and has held it in 15 quarters since. The position peaked at $14.3M in Q3 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Advisor Group held 117,270 shares of Gilead Sciences worth $7.63M as of Q4 2019.
  • Advisor Group sold 12,880 Gilead Sciences shares in Q4 2019, an estimated $839K.
  • Gilead Sciences made up 0.05% of Advisor Group's portfolio in Q4 2019, its #290 holding.
  • Advisor Group first reported a position in Gilead Sciences in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Gilead Sciences position peaked at $14.3M in Q3 2016.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.